CGC Stock Forecast 2025-2026
Distance to CGC Price Targets
CGC Price Momentum
10 Quality Stocks Worth Considering Now
Researching Canopy Growth (CGC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on CGC and similar high-potential opportunities.
Latest CGC Stock Price Targets & Analyst Predictions
Based on our analysis of 8 Wall Street analysts, CGC has a neutral consensus with a median price target of $2.29 (ranging from $0.82 to $3.76). Currently trading at $1.49, the median forecast implies a 53.8% upside. This outlook is supported by 2 Buy, 4 Hold, and 4 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CGC Analyst Ratings
CGC Price Target Range
Latest CGC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CGC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 27, 2025 | Zuanic & Associates | Pablo Zuanic | Neutral | Initiates | $0.00 |
| Jul 9, 2024 | Piper Sandler | Michael Lavery | Underweight | Maintains | $2.00 |
| Sep 15, 2023 | B of A Securities | Lisa Lewandowski | Underperform | Maintains | $0.66 |
| Jun 12, 2023 | CIBC | John Zamparo | Underperformer | Maintains | $0.50 |
| May 2, 2023 | Piper Sandler | Michael Lavery | Underweight | Maintains | $1.00 |
| Feb 17, 2023 | Cantor Fitzgerald | Pablo Zuanic | Neutral | Maintains | $3.20 |
| Nov 7, 2022 | Cantor Fitzgerald | Pablo Zuanic | Neutral | Maintains | $3.30 |
| Nov 2, 2022 | Bernstein | Nadine Sarwat | Underperform | Initiates | $1.50 |
| Oct 26, 2022 | Cantor Fitzgerald | Pablo Zuanic | Neutral | Maintains | $3.05 |
| Sep 30, 2022 | Barclays | Gaurav Jain | Underweight | Maintains | $2.00 |
| Aug 8, 2022 | Piper Sandler | Michael Lavery | Underweight | Maintains | $2.50 |
| Jun 30, 2022 | Piper Sandler | Michael Lavery | Underweight | Maintains | $3.00 |
| Jun 8, 2022 | Barclays | Gaurav Jain | Underweight | Maintains | $3.50 |
| May 31, 2022 | Piper Sandler | Michael Lavery | Underweight | Maintains | $4.00 |
| Mar 22, 2022 | Barclays | Underweight | Downgrade | $0.00 | |
| Mar 1, 2022 | Barclays | Gaurav Jain | Equal-Weight | Maintains | $9.00 |
| Feb 18, 2022 | Cantor Fitzgerald | Pablo Zuanic | Neutral | Maintains | $11.00 |
| Dec 22, 2021 | B of A Securities | Lisa Lewandowski | Underperform | Downgrade | $10.00 |
| Dec 20, 2021 | Piper Sandler | Michael Lavery | Underweight | Downgrade | $7.00 |
| Dec 7, 2021 | Wells Fargo | Underweight | Initiates | $0.00 |
Canopy Growth Corporation (CGC) Competitors
The following stocks are similar to Canopy Growth based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Canopy Growth Corporation (CGC) Financial Data
Canopy Growth Corporation has a market capitalization of $228.64M with a P/E ratio of -0.2x. The company generates $200.28M in trailing twelve-month revenue with a -169.7% profit margin.
Revenue growth is -4.8% quarter-over-quarter, while maintaining an operating margin of -26.1% and return on equity of -84.0%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Canopy Growth Corporation (CGC) Business Model
About Canopy Growth Corporation
Produces and distributes cannabis and hemp products.
The company generates revenue by producing and selling recreational and medicinal cannabis products, including dried flower, oils, softgel capsules, and edibles. Its business model emphasizes innovation through significant investments in research and development, alongside strategic partnerships and acquisitions to enhance market reach.
As one of the largest cannabis companies by market capitalization, it plays a vital role in shaping industry standards and regulations, influencing the legalization discourse globally. Canopy Growth's commitment to innovation and expansion positions it well in the evolving cannabis market.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,029
CEO
Mr. Luc Mongeau
Country
Canada
IPO Year
2018
Website
www.canopygrowth.comCanopy Growth Corporation (CGC) Latest News & Analysis
Latest News
A class action lawsuit has been filed against Canopy Growth Corporation (NASDAQ: CGC) for alleged violations of federal securities laws during the period from May 30, 2024, to February 6, 2025.
The class action lawsuit against Canopy Growth could lead to financial losses and reputational damage, affecting stock performance and investor sentiment. Legal risks may impact future profitability.
A class action lawsuit has been filed against Canopy Growth Corporation (NASDAQ: CGC) and some of its officers, according to Bronstein, Gewirtz & Grossman, LLC.
A class action lawsuit against Canopy Growth may impact its stock price and investor confidence, potentially leading to increased volatility and legal expenses for the company.
Rosen Law Firm alerts Canopy Growth Corporation (NASDAQ: CGC) securities purchasers from May 30, 2024, to February 6, 2025, of a lead plaintiff deadline on June 3, 2025.
The announcement signals potential legal issues for Canopy Growth, which may affect its stock price and investor confidence, especially as a deadline approaches for class action participation.
A class action lawsuit has been filed against Canopy Growth Corporation (NASDAQ: CGC) for alleged federal securities law violations during the period from May 30, 2024, to February 6, 2025.
A class action lawsuit against Canopy Growth Corporation could lead to financial liabilities and reputational damage, impacting stock performance and investor confidence.
The Gross Law Firm is notifying Canopy Growth Corporation (NASDAQ: CGC) shareholders about a potential lead plaintiff appointment for those who purchased shares during the specified class period.
Shareholder notices indicate potential legal issues for Canopy Growth, which could impact stock performance and investor sentiment. Legal risks often lead to volatility in share prices.
Levi & Korsinsky, LLP has filed a class action lawsuit for Canopy Growth Corporation (NASDAQ: CGC) investors, alleging securities fraud from May 30, 2024, to February 6, 2025.
The class action lawsuit against Canopy Growth may lead to significant financial liabilities, impacting stock value and investor confidence in the company.
Frequently Asked Questions About CGC Stock
What is Canopy Growth Corporation's (CGC) stock forecast for 2025?
Based on our analysis of 8 Wall Street analysts, Canopy Growth Corporation (CGC) has a median price target of $2.29. The highest price target is $3.76 and the lowest is $0.82.
Is CGC stock a good investment in 2025?
According to current analyst ratings, CGC has 2 Buy ratings, 4 Hold ratings, and 4 Sell ratings. The stock is currently trading at $1.49. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CGC stock?
Wall Street analysts predict CGC stock could reach $2.29 in the next 12 months. This represents a 53.8% increase from the current price of $1.49. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Canopy Growth Corporation's business model?
The company generates revenue by producing and selling recreational and medicinal cannabis products, including dried flower, oils, softgel capsules, and edibles. Its business model emphasizes innovation through significant investments in research and development, alongside strategic partnerships and acquisitions to enhance market reach.
What is the highest forecasted price for CGC Canopy Growth Corporation?
The highest price target for CGC is $3.76 from at , which represents a 152.6% increase from the current price of $1.49.
What is the lowest forecasted price for CGC Canopy Growth Corporation?
The lowest price target for CGC is $0.82 from at , which represents a -44.9% decrease from the current price of $1.49.
What is the overall CGC consensus from analysts for Canopy Growth Corporation?
The overall analyst consensus for CGC is neutral. Out of 8 Wall Street analysts, 2 rate it as Buy, 4 as Hold, and 4 as Sell, with a median price target of $2.29.
How accurate are CGC stock price projections?
Stock price projections, including those for Canopy Growth Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.